EFFECTIVE MANAGEMENT OF MILD-TO-MODERATE PAIN NOT RELIEVED BY IBUPROFEN OR PARACETAMOL ALONE*
This concise consultation card was developed by Guidelines for Pharmacy in partnership with Reckitt.
*Please see summary of product characteristics
Essential information and adverse reporting details are included.
RB-M-92356 June 2022
EFFECTIVE MANAGEMENT OF CONSTIPATION
This concise consultation card was developed by Guidelines for Pharmacy in partnership with Reckitt.
Essential information and adverse reporting details are included.
RB-M-92868 May 2022
Improving patient outcomes: supporting pharmacists with the management of pancreatic exocrine insufficiency (PEI)
This supplement has been commissioned, funded, and reviewed by Viatris and developed in partnership with Guidelines for Pharmacy.
Information intended for UK healthcare professionals only.
NON-2021-6348 January 2022
Management of common eye conditions: corneal and subtarsal foreign bodies
Sarah Thomas (Moorfields Eye Hospital NHS Foundation Trust) covers the symptoms and treatment of foreign bodies in the eye.
Management of common eye conditions: Glaucoma and the #knowyourdrops campaign
Sarah Thomas (Moorfields Eye Hospital NHS Foundation Trust) discusses treatment of glaucoma and techniques for correct eye drop administration.
Implementing the BSACI guideline for the diagnosis and management of allergic and non-allergic rhinitis
Information intended for healthcare professionals only.
Identifying and managing allergic rhinitis in the asthma population
This management algorithm was developed by a multidisciplinary expert panel: Scadding et al with the support of an educational grant from Mylan.
Inhaler choice guideline
This management algorithm was developed by a multidisciplinary expert panel: Usmani et al and supported by Chiesi Ltd through the provision of a grant for its production.
Guideline for the managed introduction of biosimilar basal insulin
This guideline was developed by a multidisciplinary expert panel: Down S et al with the support of an educational grant from Mylan.
Uncomplicated recurrent UTI guideline
This guideline was developed by a multidisciplinary expert panel: Rees J et al with the support of a grant from Aspire Pharma Ltd.
Stable peripheral arterial disease guideline
This guideline was developed by a multidisciplinary expert panel: Begg A et al with the support of a grant from Bayer plc.